TW202615452A - 編輯目標rna之方法 - Google Patents

編輯目標rna之方法

Info

Publication number
TW202615452A
TW202615452A TW114134167A TW114134167A TW202615452A TW 202615452 A TW202615452 A TW 202615452A TW 114134167 A TW114134167 A TW 114134167A TW 114134167 A TW114134167 A TW 114134167A TW 202615452 A TW202615452 A TW 202615452A
Authority
TW
Taiwan
Prior art keywords
leu
glu
lys
gly
val
Prior art date
Application number
TW114134167A
Other languages
English (en)
Chinese (zh)
Inventor
一瀬瑞穂
伯納德 古德曼
八木祐介
赤岩友美
島尻恭香
中村崇裕
Original Assignee
日商基因編輯力股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商基因編輯力股份有限公司 filed Critical 日商基因編輯力股份有限公司
Publication of TW202615452A publication Critical patent/TW202615452A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
TW114134167A 2020-03-31 2021-03-31 編輯目標rna之方法 TW202615452A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-065065 2020-03-31
JP2020065065 2020-03-31

Publications (1)

Publication Number Publication Date
TW202615452A true TW202615452A (zh) 2026-04-16

Family

ID=77930108

Family Applications (2)

Application Number Title Priority Date Filing Date
TW114134167A TW202615452A (zh) 2020-03-31 2021-03-31 編輯目標rna之方法
TW110112005A TWI899197B (zh) 2020-03-31 2021-03-31 編輯目標rna之方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW110112005A TWI899197B (zh) 2020-03-31 2021-03-31 編輯目標rna之方法

Country Status (11)

Country Link
US (1) US20230125942A1 (cg-RX-API-DMAC7.html)
EP (1) EP4130274A4 (cg-RX-API-DMAC7.html)
JP (4) JP7668547B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220165747A (cg-RX-API-DMAC7.html)
CN (1) CN115698296A (cg-RX-API-DMAC7.html)
AU (1) AU2021248204A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022019571A2 (cg-RX-API-DMAC7.html)
CA (1) CA3179365A1 (cg-RX-API-DMAC7.html)
IL (1) IL296955A (cg-RX-API-DMAC7.html)
TW (2) TW202615452A (cg-RX-API-DMAC7.html)
WO (1) WO2021201198A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250281571A1 (en) * 2021-04-30 2025-09-11 Osaka University Therapeutic drug for myotonic dystrophy type 1
WO2023120658A1 (ja) * 2021-12-24 2023-06-29 国立大学法人北陸先端科学技術大学院大学 酵素、複合体、組換えベクター、遺伝性疾患治療薬及びポリヌクレオチド
WO2024249445A2 (en) * 2023-05-26 2024-12-05 The Trustees Of Columbia University In The City Of New York An rna recognition and editing code of pentatricopeptide repeat proteins
CN117384884B (zh) * 2023-11-30 2024-03-08 辉大(上海)生物科技有限公司 IscB多肽及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911501A2 (pt) * 2008-04-29 2015-07-28 Monsanto Technology Llc Genes e usos para melhoramento de plantas.
ES2751126T3 (es) * 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
KR20160007541A (ko) 2013-04-22 2016-01-20 고쿠리쓰다이가쿠호진 규슈다이가쿠 피피알 모티프를 이용한 디앤에이 결합성 단백질 및 그의 이용

Also Published As

Publication number Publication date
EP4130274A1 (en) 2023-02-08
JP7698351B2 (ja) 2025-06-25
CN115698296A (zh) 2023-02-03
JPWO2021201198A1 (cg-RX-API-DMAC7.html) 2021-10-07
EP4130274A4 (en) 2024-05-22
JP2025120313A (ja) 2025-08-15
US20230125942A1 (en) 2023-04-27
JP7897387B2 (ja) 2026-07-29
JP7668547B2 (ja) 2025-04-25
AU2021248204A1 (en) 2022-11-10
WO2021201198A1 (ja) 2021-10-07
TWI899197B (zh) 2025-10-01
JP2024096897A (ja) 2024-07-17
KR20220165747A (ko) 2022-12-15
IL296955A (en) 2022-12-01
JP7698371B1 (ja) 2025-06-25
CA3179365A1 (en) 2021-10-07
BR112022019571A2 (pt) 2022-12-06
TW202204382A (zh) 2022-02-01
JP2025107239A (ja) 2025-07-17

Similar Documents

Publication Publication Date Title
CN110845603B (zh) 人胶原蛋白17型多肽、其生产方法和用途
JP7698371B1 (ja) 標的rnaを編集する方法
CN108690139B (zh) 新型融合蛋白的制备及其在提高蛋白质合成的应用
EP4021945A2 (en) Combinatorial adenine and cytosine dna base editors
CN108822209A (zh) 多肽、其生产方法和用途
JP2013507123A (ja) C型レクチンドメインをベースとするコンビナトリアルライブラリー
JP7749763B2 (ja) 凝集の少ないpprタンパク質及びその利用
CN109384833A (zh) 特异性识别甲基化修饰dna碱基的tale rvd及其应用
CN109776653B (zh) 一种人血清白蛋白黏附肽及其应用
RU2858663C2 (ru) Способ редактирования рнк-мишени
US10287342B2 (en) Polypeptide for binding to complement protein C5A, and use of same
Baumann et al. Identification of a potential modification site in human stromal cell‐derived factor‐1
US20250223576A1 (en) Optimized cas protein and use thereof
HK40080660A (zh) 编辑靶标rna的方法
US11673929B2 (en) Cyclized cytokines and method for producing same
HK40086250A (en) Method for editing target rna
CN114703215A (zh) 使用真核细胞发酵表达血管紧张素转化酶2的方法
JPS60502136A (ja) 微生物によるインタ−ル−キン2の形質発現
KR101624703B1 (ko) 적색 형광단백질에 결합하는 신규한 폴리펩타이드
WO2025191248A1 (en) Caf1 polymers comprising modified caf1 monomers
WO2025213929A1 (zh) 一种工程化胞嘧啶脱氨酶及其制备方法和用途
Albuquerque Production and characterization of INTERLEUKIN-9 and its receptor
CN122029275A (zh) 包含异源dna结合结构域的条件dna修饰酶
HK40070059A (en) Ppr protein with less aggregation and use thereof